Boothbay Fund Management
PLXP

Boothbay Fund Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Boothbay Fund Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,775
Closed -$159K – 787
2015
Q4 		$159K Sell
1,775
-480
-21% -$46.1K 0.07% 460
2015
Q3 		$253K Buy
+2,255
New +$260K 0.12% 242

Other funds holding PLXP

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Broadfin Capital
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Tourbillon Capital Partners
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Lone Star Value Management
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Frank Company
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Ardsley Advisory Partners
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Timpani Capital Management
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Boothbay Fund Management's PLXP Position: Q1 2016 in Review

Boothbay Fund Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2016, closing a stake of 1,775 shares — an estimated $159K sold.

Boothbay Fund Management first reported a position in PLXP in Q3 2015 and held it in 2 quarters. The position peaked at $253K in Q3 2015. 33 funds tracked by Wall St. Rank hold PLXP as of Q1 2016.

  • Boothbay Fund Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Boothbay Fund Management sold 1,775 PLx Pharma Inc. Common Stock shares in Q1 2016, an estimated $159K.
  • Boothbay Fund Management first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Boothbay Fund Management's PLx Pharma Inc. Common Stock position peaked at $253K in Q3 2015.
  • 33 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2016.

Based on Boothbay Fund Management's 13F filing for Q1 2016, filed 16 May 2016.